Background Documentation Breast • Invasive Carcinoma of the Breast
InvasiveBreast 4.1.0.0
8. Viale G, Dell’Orto P, Biasi MO, et al, Comparative evaluation of an extensive histopathologic examination and
a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on
axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008;247:136-142.
9. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node
metastases in patients with early-stage breast cancer. J Clin Oncol. 2008;26:3338-3345.
10. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6
th
edition of the
American Joint Committee on Cancer Staging Manual. Cancer. 2003;90:2740-2741.
11. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. WHO Classification of Tumours of the Breast,
Fourth ed. Geneva, Switzerland: WHO Press; 2012.
12. Ellis IO, Elston CW. Histologic grade. In: O’Malley FP, Pinder SE, eds. Breast Pathology. Philadelphia, PA:
Elsevier; 2006:225-233.
13. Pathology Reporting of Breast Disease. A Joint Document Incorporating the Third Edition of the NHS Breast
Screening Programme’s Guidelines for Pathology Reporting in Breast Cancer Screening and the Second
Edition of The Royal College of Pathologists’ Minimum Dataset for Breast Cancer Histopathology Published
by the NHS Cancer Screening Programmes jointly with The Royal College of Pathologists. NHSBSP
Publication No 58. January 2005. http://www.cancerscreening.nhs.uk/
breastscreen/publications/nhsbsp58.html. Accessed April 8, 2009.
14. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and
lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94:1383-1390.
15. Morrow M, Harris JR. Local management of invasive breast cancer (chapter 33). In: Harris JR, Lippman ME,
Morrow M, Osborne KE, eds. Diseases of the Breast. 2
nd
ed. Philadelphia, PA: Lippincott Williams & Wilkins;
2000:522-523.
16.
Fitzgibbons PL, Bose S, Chen Y, et al. Protocol for the Examination of Specimens
From Patients with Ductal Carcinoma In Situ (DCIS) of the Breast
. 2017; www.cap.org/cancerprotocols.
17. Schwartz GF, Lagios MD, Carter D, et al. Consensus conference on the classification of ductal carcinoma in
situ. Cancer. 1997;80:1798-1802.
18. Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-
sparing mastectomies. Ann Surg Oncol. 2005;12(12):1037-1044.
19. Sahoo S, Lester SC. Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with
recommendations on specimen processing and reporting. Arch Pathol Lab Med. 2009;133:633-642.
20. Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F. Issues in the assessment of the pathologic effect of primary
systemic therapy for breast cancer. Breast Cancer. 2006;13:38-48.
21. Pinder SE, Provenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens
from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50:409-417.
22. Gonzalez MA, Pinder SE. Invasive carcinoma: other histologic prognostic factors – size, vascular invasion
and prognostic index. In: O’Malley FP, Pinder SE, eds. Breast Pathology. Philadelphia, PA: Elsevier; 2006:
235-240.
23. Colleoni M, Rotmensz N, Maisonneuve P, et al. Prognostic role of the extent of peritumoral vascular invasion
in operable breast cancer. Ann Oncol. 2007;18:1632-1640.
24. Mohammed RA, Martin SG, Mahmmod AM, et al. Objective assessment of lymphatic and blood vessel
invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
J Pathol. 2011;223:358-365.
25. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis
and clinical significance. Pathol Annu. 1983;18 Pt 2:215-232.
26. Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes-dealing with the diversity of breast cancer:
highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer
2011. Ann Oncol. 2011;22:1736-1747.